Albany, NY -- (SBWIRE) -- 05/30/2014 -- Market Snapshot: Glucose Monitoring Devices 2014 - Southeast Asia” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key company share data by revenue and volume in 2013 for the following countries: Taiwan, Indonesia, Malaysia, Singapore and Vietnam. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

View Full Report With Complete TOC or Request Sample of This Report at http://www.researchmoz.us/market-snapshot-glucose-monitoring-devices-2014-southeast-asia-report.html

Scope
Information on market size for the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips
Annualized sales data by revenue for the 2006–2020 period and company share data by revenue for 2013
Annualized sales data by volume for the 2006–2020 period and company share data by volume for 2013
Coverage of key geographies: Malaysia, Singapore, Indonesia, Vietnam and Taiwan

Reasons to Buy

Derive actionable insights from value-volume relationships
Analyze value-volume relationships and provide direction to marketing and sales strategies
Develop market-entry and market-expansion strategies
Identify the key players best positioned to take advantage of opportunities in the Southeast Asian market

Browse other Published Reports by GBI Research at http://www.researchmoz.us/publisher/gbi-research-2.html

latest Published Report -

Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation

Psoriasis is a chronic, inflammatory disease triggered by deregulated Thymus-derived (T) cells, resulting inflammation and benign hyperplasia of keratinocytes within the skin. Manifestations of affected skin are red, thickened plaques with an overlying silver-white scale, which significantly impairs the patient’s physical and mental wellbeing. The primary cause of psoriasis is unknown, as are the mechanisms that lead to immune cells directing inflammatory responses towards the skin. Within the lucrative autoimmune market, the psoriasis market has grown considerably due to the repositioning of all three marketed Tumor Necrosis Factor (TNF) inhibitors: Humira (adalimumab) and Enbrel (etanercept) which were originally approved for rheumatoid arthritis, and also Remicade (infliximab), the first biologic to be approved for Crohn’s disease, an autoimmune disease which largely affects the gastrointestinal system.

View Full Report With Complete TOC at http://www.researchmoz.us/frontier-pharma-psoriasis-identifying-and-commercializing-first-in-class-innovation-report.html

About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Email: sales@researchmoz.us

Browse Blog - http://medicaldevicesoverview.wordpress.com/